Eledon Pharmaceuticals (ELDN) Other Working Capital Changes (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Other Working Capital Changes of -$86000.0 for Q1 2026, down 16.22% year-on-year from -$102645.2 in Q1 2025, and up 87.73% on a QoQ basis from -$701000.0 in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Other Working Capital Changes data on file, last reported at -$86000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 16.22% year-over-year to -$86000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 299.04% YoY), and the FY2025 full-year result was -$1.2 million, down 266.08% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$86000.0, up from -$701000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.4 million in Q4 2022 and bottomed at -$1.5 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is -$91000.0 (2022), against an average of -$157823.5.
- Peak annual rise in Other Working Capital Changes reached 660.0% in 2022, while the deepest fall reached 2434.04% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $1.4 million in 2022, then plunged by 150.35% to -$719000.0 in 2023, then soared by 287.2% to $1.3 million in 2024, then tumbled by 152.08% to -$701000.0 in 2025, then surged by 87.73% to -$86000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$86000.0 (Q1 2026), -$701000.0 (Q4 2025), and -$389000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86,000.00 |
| Mar 31, 2026 | -86,000.00 |
| Dec 31, 2025 | -701,000.00 |
| Dec 31, 2025 | -701,000.00 |
| Sep 30, 2025 | -389,000.00 |
| Sep 30, 2025 | -389,000.00 |
| Jun 30, 2025 | -77,000.00 |
| Jun 30, 2025 | -77,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.52 Mn |
| Jun 30, 2024 | -67,000.00 |
| Jun 30, 2024 | -67,000.00 |
| Mar 31, 2024 | -99,000.00 |
| Mar 31, 2024 | -99,000.00 |
| Dec 31, 2023 | -719,000.00 |
| Dec 31, 2023 | -719,000.00 |
| Sep 30, 2023 | 1.15 Mn |
| Sep 30, 2023 | 1.15 Mn |
| Jun 30, 2023 | -713,000.00 |
| Jun 30, 2023 | -713,000.00 |
| Mar 31, 2023 | -78,000.00 |
| Mar 31, 2023 | -78,000.00 |
| Dec 31, 2022 | 1.43 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | -800,000.00 |
| Sep 30, 2022 | -800,000.00 |
| Jun 30, 2022 | -1.19 Mn |
| Jun 30, 2022 | -1.19 Mn |
| Mar 31, 2022 | -91,000.00 |
| Mar 31, 2022 | -91,000.00 |
| Dec 31, 2021 | -255,000.00 |
| Dec 31, 2021 | -255,000.00 |
| Sep 30, 2021 | 149,000.00 |
| Sep 30, 2021 | 149,000.00 |
| Jun 30, 2021 | -47,000.00 |
| Jun 30, 2021 | -47,000.00 |
| Mar 31, 2021 | -47,000.00 |
| Mar 31, 2021 | -47,000.00 |
| Dec 31, 2020 | 591,000.00 |
| Dec 31, 2020 | 591,000.00 |
| Sep 30, 2020 | -683,000.00 |
| Sep 30, 2020 | -683,000.00 |
| Jun 30, 2020 | -45,000.00 |
| Jun 30, 2020 | -45,000.00 |
| Mar 31, 2020 | -43,000.00 |
| Mar 31, 2020 | -43,000.00 |
| Dec 31, 2019 | -162,000.00 |
| Dec 31, 2019 | -162,000.00 |
| Sep 30, 2019 | 77,000.00 |
| Sep 30, 2019 | 77,000.00 |
| Jun 30, 2019 | 23,000.00 |
| Jun 30, 2019 | 23,000.00 |
| Mar 31, 2019 | -103,000.00 |
| Mar 31, 2019 | -103,000.00 |
| Dec 31, 2018 | 453,000.00 |
| Dec 31, 2018 | 453,000.00 |
| Sep 30, 2018 | -169,000.00 |
| Sep 30, 2018 | -169,000.00 |
| Jun 30, 2018 | 384,000.00 |
| Jun 30, 2018 | 384,000.00 |
| Mar 31, 2018 | -192,000.00 |
| Mar 31, 2018 | -192,000.00 |
| Dec 31, 2017 | -244,000.00 |
| Dec 31, 2017 | -244,000.00 |
| Sep 30, 2017 | -406,000.00 |
| Sep 30, 2017 | -406,000.00 |
| Jun 30, 2017 | 1.17 Mn |
| Jun 30, 2017 | 1.17 Mn |
| Mar 31, 2017 | -7,000.00 |
| Mar 31, 2017 | -7,000.00 |
| Dec 31, 2016 | -23,000.00 |
| Dec 31, 2016 | -23,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 476,000.00 |
| Jun 30, 2016 | 476,000.00 |
| Mar 31, 2016 | -521,000.00 |
| Mar 31, 2016 | -521,000.00 |
| Dec 31, 2015 | -1.46 Mn |
| Dec 31, 2015 | -1.46 Mn |
| Sep 30, 2015 | 200,000.00 |
| Sep 30, 2015 | 200,000.00 |
| Jun 30, 2015 | 1.26 Mn |
| Jun 30, 2015 | 1.26 Mn |
| Mar 31, 2015 | 45,000.00 |
| Mar 31, 2015 | 45,000.00 |
| Dec 31, 2014 | 995,000.00 |
| Dec 31, 2014 | 995,000.00 |
| Sep 30, 2014 | 764,000.00 |
| Sep 30, 2014 | 764,000.00 |
| Jun 30, 2014 | -273,000.00 |
| Jun 30, 2014 | -273,000.00 |
| Mar 31, 2014 | 344,000.00 |
| Mar 31, 2014 | 344,000.00 |
| Dec 31, 2013 | 10,000.00 |
| Dec 31, 2013 | 10,000.00 |